Growing evidence indicates that dysregulation of the JAK/STAT pathway is implicated in multiple human cancers, including breast, gastric, lung, and ovarian cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma [69,70,71,72,73,74,75]. Here, SOAT1 is linked to hepatocellular carcinoma.